Levisticum Quercus NDC 48951-6032

NDC codes

FDA NDC Directory

Product NDC (as listed)48951-6032Labeler and product segments. Claims need a package NDC.

Product NDC at billing width48951-6032Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
48951-6032-2	48951603202	1350 PELLET in 1 BOTTLE, GLASS (48951-6032-2)Marketed from Sep 1, 2009

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levisticum Quercus
Generic name (nonproprietary): levisticum quercus
Active ingredients: Quercus robur whole — 6 [hp_X]/1Bos taurus eye — 6 [hp_X]/1Levisticum officinale root — 6 [hp_X]/1
Dosage form: Pellet
Route: Oral
Labeler: Uriel Pharmacy Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Sep 1, 2009
Listing expires: Dec 31, 2026
Identifiers: Product ID 48951-6032_2cb7da11-08b0-16a6-e063-6294a90a264fSPL ID 2cb7da11-08b0-16a6-e063-6294a90a264fSPL set ID 58d8b1be-ffd9-49ff-8512-6bc73a47e995UNII R7QMG0BT2W, VTW461N43P, 46QZ19OEX8

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N448951603202 followed by a unit qualifier and the quantity

Package 48951-6032-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 27, 2025.

Indications (excerpt from the label)

Directions: FOR ORAL USE ONLY.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)